Sustainability | February 19, 2025
Lupin receives “A-” leadership rating from CDP in climate change and water security
This rating reflects Lupin's leadership in environmental transparency and performance
This rating reflects Lupin's leadership in environmental transparency and performance
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Phase 3 study results will form the basis for future discussions with global regulatory authorities
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
Biocon has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
